Pityriasis Alba in Emergency Medicine Clinical Presentation

  • Author: Rashid M Rashid, MD, PhD; Chief Editor: Pamela L Dyne, MD   more...
 
Updated: Feb 27, 2012
 

History

  • Pityriasis alba lesions often occur on the face. In particular, the cheek is a common site.[2]
  • Lesions may be erythematous or pruritic in the beginning, evolving into scaly, hypopigmented macules. Patients may complain that lesions are more prominent in the summer, secondary to the surrounding hyperpigmentations associated with prolonged sun exposure.
Next

Physical

  • A flaky, hypopigmented, patchy dermatitis with fine scales involving the face and, at times, the neck and shoulders typically is found.
  • Numerous (up to 20 or more) hypopigmented macules, which are ill defined and range in size from 1-4 cm, can be found (see the image below). Lesions of pityriasis alba are usually bilateral aLesions of pityriasis alba are usually bilateral and located on the face, arms, and neck.
  • The lesions of pityriasis alba tend to have less well-defined borders than lesions seen in vitiligo, and they do not coalesce as seen in tinea versicolor.
  • An association with atopy is believed to exist; therefore, some patients may have atopic dermatitis as well.
  • Other clues of atopic changes can help and also distinguish atopic from atopiform patients. These include Dennie-Morgan folds, perioral pallor, and a horizontal nasal crease on the root of the nose. In particular, a history of atopy, recurrent conjunctivitis, palmar hyperlinearity, keratosis pilaris, pityriasis alba, and hand and/or food eczema were significantly less present in atopiform dermatitis. Dennie-Morgan fold was positively associated with atopiform dermatitis.[4]
Previous
Next

Causes

No definitive etiologic agent has been described for pityriasis alba.

Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

Rashid M Rashid, MD, PhD  Resident Physician, Department of Dermatology, University of Texas, Houston, MD Anderson Cancer Center, and Morzak Research Initiative

Rashid M Rashid, MD, PhD is a member of the following medical societies: American Academy of Dermatology, Council for Nail Disorders, Houston Dermatological Society, Texas Dermatological Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Andrew C Miller, MD  Fellow, Department of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center (UPMC); Attending Physician, Department of Emergency Medicine, UPMC St Margaret's Hospital

Andrew C Miller, MD is a member of the following medical societies: American Medical Association

Disclosure: Nothing to disclose.

Mark A Silverberg, MD, MMB, FACEP  Assistant Professor, Associate Residency Director, Department of Emergency Medicine, State University of New York Downstate College of Medicine; Consulting Staff, Department of Emergency Medicine, Staten Island University Hospital, Kings County Hospital, University Hospital, State University of New York Downstate Medical Center

Mark A Silverberg, MD, MMB, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

David A Peak, MD  Assistant Residency Director of Harvard Affiliated Emergency Medicine Residency, Attending Physician, Massachusetts General Hospital; Consulting Staff, Department of Hyperbaric Medicine, Massachusetts Eye and Ear Infirmary

David A Peak, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Society for Academic Emergency Medicine, and Undersea and Hyperbaric Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Mark W Fourre, MD  Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD  Professor of Clinical Medicine/Emergency Medicine, University of California, Los Angeles, David Geffen School of Medicine; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors, Dara A Kass, MD, Richard H Sinert, DO, and Reza Keshavarz, MD, to the development and writing of this article.

References

  1. Di Lernia V, Ricci C. On atopic and idiopatic extensive pityriasis alba. Pediatr Dermatol. Sep-Oct 2007;24(5):578-9. [Medline].

  2. Vinod S, Singh G, Dash K, Grover S. Clinico epidemiological study of pityriasis alba. Indian J Dermatol Venereol Leprol. Nov-Dec 2002;68(6):338-40. [Medline].

  3. In SI, Yi SW, Kang HY, Lee ES, Sohn S, Kim YC. Clinical and histopathological characteristics of pityriasis alba. Clin Exp Dermatol. Jul 2009;34(5):591-7. [Medline].

  4. Brenninkmeijer EE, Spuls PI, Legierse CM, Lindeboom R, Smitt JH, Bos JD. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol. Mar 2008;58(3):407-14. [Medline].

  5. Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol. Jul 2007;46(7):700-5. [Medline].

  6. Al-Mutairi N, Hadad AA. Efficacy of 308-nm Xenon Chloride Excimer Laser in Pityriasis Alba. Dermatol Surg. Nov 28 2011;[Medline].

  7. Lin RL, Janniger CK. Pityriasis alba. Cutis. Jul 2005;76(1):21-4. [Medline].

  8. Ortonne JP, Passeron T. Melanin pigmentary disorders: treatment update. Dermatol Clin. Apr 2005;23(2):209-26. [Medline].

  9. Rakel RE, Bope ET. Conn's Current Therapy 2005. 57th ed. St Louis: WB Saunders; 2005:999.

  10. Sams WM. Principles and Practice of Dermatology. New York: Churchill; 1990:369.

  11. Vargas-Ocampo F. Pityriasis alba: a histologic study. Int J Dermatol. Dec 1993;32(12):870-3. [Medline].

 
Previous
Next
 
Note the characteristic, ill-defined, hypopigmented macules in this 6-year-old child with pityriasis alba.
Lesions of pityriasis alba are usually bilateral and located on the face, arms, and neck.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.